跳至主要内容
临床试验/ISRCTN16351033
ISRCTN16351033已完成未知

A training and service intervention to optimise pharmacist-based treatment for smoking cessation: a cluster randomised controlled trial

Queen Mary University of London0 个研究点目标入组 1,272 人开始时间: 2018年4月3日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
1,272

研究概览

简要总结

2019 Results article in https://www.ncbi.nlm.nih.gov/pubmed/31110097 results 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35761321/ (added 28/06/2022) 2019 Protocol article in https://doi.org/10.1186/s13063-019-3368-6 (added 10/05/2024)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • NHS SSP eligibility criteria:
  • 1. Current smokers aged 18 and above
  • 2. All types of smoking (cigarettes, cigar, pipe)

排除标准

  • Exclusion criteria for community pharmacies and pharmacy staff:
  • 1. Sites that lack the facilities for secure storage and transfer of the study data
  • 2. Advisors who refuse GCP training
  • Exclusion criteria for service users who will be part of the study exploring individual participant level outcomes:
  • 1. Non-smokers
  • 2. Unable to understand the STOP study service user information sheet and consent form
  • 3. Unable/unwilling to give written informed consent for STOP study additional data collection procedures for detailed analysis
  • Note: The risks and benefits of nicotine replacement need to be explained to pregnant or breastfeeding women and to people who have unstable cardiovascular disorders according to usual practice in the NHS Stop Smoking Service. Neither varenicline nor bupropion should be offered to pregnant or breastfeeding women. Varenicline or bupropion may be offered to people with unstable cardiovascular disorders, subject to clinical judgement
  • https://www.nice.org.uk/guidance/PH10/chapter/1-Key-priorities

研究者

相似试验

A training and service intervention to optimise... | 临床试验